Follow-up of renal impairment results among attendees taking HIV Pre-Exposure Prophylaxis at a Sydney Sexual Health Clinic

被引：2

作者：

Comninos, N. B. ^{[1
]}

Foster, R. ^{[1
,2
]}

Varma, R. ^{[1
,2
]}

Bourne, C. ^{[1
,2
,3
]}

机构：

[1] South Eastern Sydney Local Hlth Dist, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia

[2] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia

[3] NSW Minist Hlth, STI Programs Unit, Sydney, NSW, Australia

来源：

INTERNATIONAL JOURNAL OF STD & AIDS | 2020年 / 31卷 / 07期

关键词：

Australia; prevention; human immunodeficiency virus; EXPOSURE;

D O I：

10.1177/0956462420922751

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Renal monitoring is recommended for Pre-Exposure Prophylaxis (PrEP) users. We aimed to explore follow-up and outcomes among PrEP users with renal impairment (defined as estimated glomerular filtration rate <65 mL/min/1.73 m(2)) attending Sydney Sexual Health Centre. Time to follow-up was analysed for impairment results over a 12-month period (January-December 2018); 48/2504 (1.9%) tests among 1700 attendees showed impairment. Follow-up occurred in 39/48 (81.3%) impairment results after a median of 42 days. PrEP was ceased in 3/6 cases of non-resolving/persisting impairment, with one case of subsequent human immunodeficiency virus infection. Maintaining engagement and follow-up of those with renal impairment are important aspects of PrEP service provision.

引用

页码：689 / 693

页数：5

共 8 条

[1]

[Anonymous], 2018, J VIRUS ERAD

[2] Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study [J].

Gandhi, Monica ;

Glidden, David V. ;

Mayer, Kenneth ;

Schechter, Mauro ;

Buchbinder, Susan ;

Grinsztejn, Beatriz ;

Hosek, Sybil ;

Casapia, Martin ;

Guanira, Juan ;

Bekker, Linda-Gail ;

Louie, Alexander ;

Horng, Howard ;

Benet, Leslie Z. ;

Liu, Albert ;

Grant, Robert M. .

LANCET HIV, 2016, 3 (11) :E521-E528

[3]

Liegeon G, 2019, C RETR OPP INF CROI

[4]

Mills A., 2019, OPEN FORUM INFECT DI, V6, DOI [10.1093/ofid/ofz359.139, DOI 10.1093/OFID/OFZ359.139]

[5]

Primary Health Advisory Committee for Kidney Health Australia, CHRON KIDN DIS MAN H

[6] Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre- exposure prophylaxis [J].

Solomon, Marc M. ;

Lama, Javier R. ;

Glidden, David V. ;

Mulligan, Kathleen ;

McMahan, Vanessa ;

Liu, Albert Y. ;

Vicente Guanira, Juan ;

Veloso, Valdilea G. ;

Mayer, Kenneth H. ;

Chariyalertsak, Suwat ;

Schechter, Mauro ;

Bekker, Linda-Gail ;

Kallas, Esper Georges ;

Burns, David N. ;

Grant, Robert M. .

AIDS, 2014, 28 (06) :851-859

[7]

The Australasian Society of HIV Viral Hepatitis and Sexual Health Medicine (ASHM) PrEP Guidelines Update, 2019, PREV HIV PRESCR PREP

[8] Automated, Computer Generated Reminders and Increased Detection of Gonorrhoea, Chlamydia and Syphilis in Men Who Have Sex with Men [J].

Zou, Huachun ;

Fairley, Christopher K. ;

Guy, Rebecca ;

Bilardi, Jade ;

Bradshaw, Catriona S. ;

Garland, Suzanne M. ;

Sze, Jun Kit ;

Afrizal, Afrizal ;

Chen, Marcus Y. .

PLOS ONE, 2013, 8 (04)

← 1 →